New Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India has directed manufacturers and importers of primary and revision knee implants to furnish price data to the authority.
NPPA has requested the companies to furnish the data as per the format provided by NPPA in both hard and soft copies and send to NPPA latest by 30th July 2018. The soft copy of the data to be emailed to email@example.com.
The authority has directed 15 companies to furnish the data including Meril Life Sciences.
In Aug 2017, Medical Dialogues had reported that National Pharmaceuticals Pricing had fixed the ceiling prices of orthopaedic knee implants for knee replacement system and capped the prices of knee implants at a significantly lower rate than current market rates.
The NPPA had fixed the price for primary knee replacement of titanium alloy at Rs 38,740 while the price for revision knee replacement of any material was pegged at Rs 62,770. The price of price for Hi-Flex primary knee replacement has been fixed at Rs 25,860 and that of cobalt chromium alloy at Rs 24,090.
The prices for other primary knee replacement surgeries of femoral component, such as oxidised zirconium, had been fixed at Rs 38,740 by the pharma sector price regulator.
The prices capped for primary knee replacement for tibial component or tibial tray made of titanium alloy and oxidised zirconium had been fixed at Rs 24,280.
Below is the attachment for the same